Scopolamine Patch for Clozapine-Induced Sialorrhea [1]

Psychiatric Services

Volumn 55, Issue 3, 2004, Pages 318-

  Gaftanyuk, Olga ^a   Trestman, Robert L ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Department of Psychiatry ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CLOZAPINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; PIRENZEPINE; SCOPOLAMINE; NEUROLEPTIC AGENT;

ADULT; CASE REPORT; CHOLINERGIC SYSTEM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; HYPERSALIVATION; LETTER; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; CHEMICALLY INDUCED DISORDER; INTRADERMAL DRUG ADMINISTRATION; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; SCOPOLAMINE; SIALORRHEA; UNITED STATES;

EID: 10744220784     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.3.318     Document Type: Letter

References (5)

1. Lieberman JA: Maximizing clozapine treatment: managing side effects. Journal of Clinical Psychiatry 59(suppl 3):38-43, 1998
2. Miller DD: Review and management of clozapine side effects. Journal of Clinical Psychiatry 61(suppl 8):14-17, 2000
3. Young CR, Bowers MB, Mazure CM: Management of the adverse effects of clozapine. Schizophrenia Bulletin 24:381-390, 1998
4. Naber D: Optimizing clozapine treatment. Journal of Clinical Psychiatry 60(suppl 12):35-38, 1999
5. Antonello C, Tessier P: Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect. Journal of Psychiatry and Neuroscience 24:250, 1999